論文・技術情報追加のお知らせ

①Hyponatraemia following antipsychotic treatment: In-silico pharmacodynamics analysis of spontaneous reports from the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review.

抗精神病薬治療後の低ナトリウム血症の症例対照研究とシステマティックレビュー

対象DB：FAERS

②Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.

プロトンポンプ阻害剤と急性腎障害および慢性腎臓病との関連調査研究

対象DB：FAERS

③SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system.

SGLT-2阻害薬と心房細動のファーマコビジランス研究

対象DB：FAERS

④Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS).

ポリミキシン（コリスチンとポリミキシンB）と腎毒性に関する調査研究

対象DB：FAERS

⑤Pharmacotherapy Management for COVID-19 and Cardiac Safety: A Data Mining Approach for Pharmacovigilance Evidence from the FDA Adverse Event Reporting System (FAERS).

抗マラリア薬、抗ウイルス薬、抗生物質薬を含むCOVID-19の薬物療法に関連した心臓有害事象のリスク調査研究

対象DB：FAERS

⑥Correlations Between SGLT-2 Inhibitors and Acute Renal Failure by Signal Detection Using FAERS: Stratified Analysis for Reporting Country and Concomitant Drugs.

SGLT-2阻害薬と急性腎不全との相関調査研究：報告国および併用薬の層別分析

対象DB：FAERS

⑦Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy.

GLP-1RAと糖尿病網膜症イベントを対象とした不均衡を評価するための個別用語と複合用語の使用比較研究

対象DB：FAERS

⑧Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review.

妊娠中のインフラマソーム標的治療におけるFAERS分析とシステマティックレビューレビュー

対象DB：FAERS

⑨Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemic.

COVID-19パンデミック期間のヒドロキシクロロキン、アジスロマイシン、クロロキン有害事象報告概要

対象DB：FAERS

⑩Safety profiles of new xanthine oxidase inhibitors: A post-marketing study.

キサンチンオキシダーゼ阻害剤の安全性プロファイル研究

対象DB：JADER

⑪Fatal and life-threatening ADRs associated with paliperidone palmitate: an observational study in the French pharmacovigilance database.

パルミチン酸パリペリドン関連した致死的および生命を脅かす有害事象調査研究

対象DB：FPVD